Intake of Boron, Cadmium, and Molybdenum enhances rat thyroid cell transformation
- Emilia Luca†1,
- Laura Fici†1, 2,
- Anna Ronchi3,
- Ferdinando Marandino4,
- Esther Diana Rossi1,
- Maria Emiliana Caristo1,
- Pasqualino Malandrino5,
- Marco Russo5,
- Alfredo Pontecorvi†1,
- Riccardo Vigneri†5, 6Email author and
- Fabiola Moretti†2, 7Email author
© The Author(s). 2017
Received: 15 February 2017
Accepted: 25 May 2017
Published: 2 June 2017
Epidemiologic data in volcanic areas suggest that environmental factors might be involved in the increase of thyroid cancer (TC) incidence. Recent reports indicate that several heavy metals and metalloids are increased in volcanic areas. This study aims to evaluate the combined effect of three of these elements Boron (B), Cadmium (Cd), and Molybdenum (Mo) - all increased in the volcanic area of Mt. Etna, in Italy - on thyroid tumorigenesis in the rat.
Female Wistar rats prone to develop thyroid tumors by low-iodine diet and methimazole treatment received ad libitum drinking water supplemented with B, Cd, and Mo at concentrations in the range found in the urine samples of residents of the volcanic area. At 5 and 10 months animals were euthanized, and their thyroid analysed. Statistical analysis was performed with a 2-way unpaired t-test.
No toxic effect of the three elements on the growth of the animals was observed. A significant increase of histological features of transformation was observed in thyroid follicular cells of rats treated with B, Cd, and Mo compared with those of control group. These abnormalities were associated with decreased iodine content in the thyroid.
This study provides the evidence that slightly increased environmental concentrations of B, Cd, and Mo can accelerate the appearance of transformation marks in the thyroid gland of hypothyroid rats.
Thyroid cancer (TC) incidence has continuously and sharply risen since the early 1990s, more than any other cancer type. At present, TC is the 5th most frequent cancer in women, whereas it ranked 14th twenty years ago [1–3]. The causes underlying this increase are currently disputed. Some authors have suggested that this increase is apparent because of a more widespread use of screening and diagnosis of small tumors with minimal clinical relevance that went undetected in the past. Although a contribution of over-diagnosis is likely, some evidence indicates that a real increase is also occurring [4, 5]; indeed, the occurrence of large (>4 cm) thyroid tumors is also increased, and TC mortality rate is recently growing in spite of earlier diagnosis and better treatment.
Because of the rapid change observed in TC incidence, it is reasonable that environmental rather than genetic factors are involved. At present, the best known environmental factors able to promote thyrocyte growth and malignant transformation are radiation and iodine deficiency . Radiation is a well-known risk factor for many cancer types, and the thyroid is a radiosensitive organ, especially at a young age, as demonstrated by the Chernobyl accident . Chronic iodine deficiency represents a well-known determinant of follicular cell hyperplasia with thyroid hypertrophy (goiter) observed in both animal models and humans [8, 9]. The mechanism underlying the effects of low-iodine intake seems to rely on the increase of TSH levels that stimulate thyroid cells proliferation. In addition to radiation and iodine deficiency, environmental disruptors can also affect thyroid function and proliferation. For instance nitrates, frequent contaminants of water in areas of intensive agricultural industry can behave as potential thyroid function disruptor and carcinogen .
Epidemiologic studies performed in volcanic areas in different regions of the world have shown a marked increase in TC incidence, suggesting that unknown environmental factors of volcanic origin might contribute to the development of thyroid carcinoma [11–14]. These studies have also been performed in the volcanic area of Mt. Etna in Sicily, the largest active volcano in Europe, which has a large aquifer providing drinking water and irrigation for approximately 700,000 inhabitants. In this area, thyroid cancer incidence is doubled in comparison to the rest of Sicily and the increase is related exclusively to the papillary histotype .
In the same area, the levels of some heavy metals and metalloids are raised in drinking water and lichens compared with those of the adjacent non-volcanic areas. Human bio-contamination is demonstrated by the increase of these elements in the urine specimens of the residents, although with values in the normal range in most of the cases . Within this multi-elemental pollution, it is hard to identify which element(s) may have a detrimental effect on thyroid function and transformation.
In this work, using a well-established in vivo model of thyroid tumorigenesis, we have undertaken a pilot study to analyse the effect on the thyroid of a combination of three elements: Boron (B), Cadmium (Cd), and Molybdenum (Mo). These elements are increased both in the environment (water and lichens) and in the urine samples of residents of the Mt. Etna volcanic area .
We have investigated the effect of chronic exposure to slightly increased concentrations of these elements (in the same range found in the urine samples of volcanic area residents) and, to better mimic the volcanic area conditions, the effect of each metal was not investigated individually but in combination with the other compounds. This choice was based on the assumption that, since average metal levels in the volcanic area are within the MAC (Maximal Admissible Concentration), the most likely hypothesis is that their combination rather than a single element may affect thyroid tumorigenesis.
B is the element at the highest concentration in the urine samples of the volcanic area residents and is one of the few chemicals whose increase in urines exceeded the urine reference limits in some individuals (over 20%) of the volcanic area population . B has been reported to affect thyroid hormone concentration in gilts  and to be increased in the hair of children with goiter ;
Mo levels are over ten times increased in drinking water of the volcanic area compared with that of adjacent areas, and its urine concentration in volcanic area residents is higher than normal limits in more than 20% cases . Mo has been reported to interact with the thyroid hormone receptor  and to significantly correlate with urinary iodine levels ;
Cd levels are more than ten times increased in the volcanic area water ; Cd is a well-recognized carcinogen (group 1 carcinogen according to the IARC classification)  although at concentrations higher than those used in this study. Cd has also been reported to accumulate in the thyroid  and, after chronic exposure, to be associated with increased thyroid hormone levels  and pre-neoplastic thyroid abnormalities . Moreover, levels of Cd are higher in thyroid tissue of patients with advanced thyroid cancer .
Elements, compounds, and concentration [C] used for animal treatment
[C] of element in urine samples
[C] of element in drinking water of Group B
Compound used in drinking water (MW)
[C] of compound in drinking water of Group B
LD50 compound in rat
800 μg/L (74 μM)
1600 μg/L (148 μM)
Boric Acid (61.83)
0.2 μg/L (1.8 nM)
0.4 μg/L (3.6 nM)
Cadmium Chloride (183.32)
50 μg/L (0.52 μM)
100 μg/L (1.04 μM)
Ammonium heptamolybdate tetrahydrate (1235.86)
Twenty-eight female Wistar rats (9 weeks old, 200–230 g) obtained from the animal service of the Catholic University of Rome, were kept under standard housing conditions (temperature 21°–23 °C, relative humidity 45–65%, and 12 h:12 h light/dark cycle) with aseptic food and tap water ad libitum. All animals were housed in plastic cages containing two or three animals/cage. All rats but two were treated with drinking water containing 0.003% methimazole (MMI) and low-iodine diet (Remington’s Diet, Mucedola) to make them hypothyroid. The two untreated female rats were grown under the same housing conditions but without MMI and low-iodine diet and their thyroid was used as normal control for histological analysis. Experimental rats were randomly divided into two groups (11 rats/group A, 15 rats/group B). Control group A received drinking water containing 0.003% MMI (Sigma-Aldrich) and low-iodine diet. Rats in group B were given, in addition, two heavy metals (Cd, and Mo) and one metalloid (B) dissolved in drinking water at the concentration and under the chemical form reported in Table 1.
All animal experiments were approved by the ethical committee of the Catholic University of Rome, Italy (n. Q42), and were conducted in accordance with institutional guidelines, which are in compliance with national (D.L. No. 116, G.U., Suppl. 40, Feb. 18, 1992; Circular No. 8,G.U., July 1994) and international laws (EEC Council Directive 86/609, OJ L 358. 1, Dec 12, 1987; Guide for the Care and Use of Laboratory Animals, United States National Research Council, 1996) on the ethical use of animals.
Clinical observation of animals was carried out daily, and body weight was measured every 2 weeks. After 1, 5 and 10 months from the beginning of treatment, three rats from both control and treated groups were housed in metabolic cages, and 24 h urine samples were collected and stored at -80 °C for iodine and metal analysis.
After 5 and 10 months, 5 and 6 rats from Group A, and 5 and 10 rats from Group B, respectively were anesthetized with Ketamine (75 mg/kg i.m.) and medetomidine (0.5 mg/kg i.m.) and killed by exsanguination. Thyroid portions were collected as follows: a) formalin-fixed-paraffin-embedded (FFPE) tissue sample for histopathological examination; b) tissue specimen stored at -80 °C immediately after harvesting for subsequent iodine and B, Cd and Mo analysis.
Follicular size (size less than 0.5 mm was classified as micro);
Cellular morphology: ranging from flat in normal thyroid, to cuboidal with hyperplastic or neoplastic features. Hyperplastic features are defined by the presence of nuclear clearing and/or granular inclusion; neoplastic features are defined by nuclear clearing with the presence of pseudo-inclusions;
Disomogeneity (defined as nodular hyperplasia for the presence of parenchyma with either pseudonodular or nodular pattern and with hyperplastic features characterised by oxyphilic cellular changes and some nuclear/cytoplasmic clearing and pseudo-inclusions);
Presence of oxyphilic cells, and/or granular cells;
Presence of inflammation features
The diagnosis of papillary thyroid carcinoma was based on the presence of papillary structures with distinctive nuclear features (pleomorphic nuclei, grooves, nuclear pseudo-inclusion) and micro or medium-follicular structures with evidence of capsular invasion.
Pictures were analysed by optical microscope BX53F (Olympus Corp., Tokyo, Japan).
Instrument Operating Parameters for DRC-ICP-MS analysis
Sample flow rate
Number of replicates
1 min 39 s
Sample read delay
Autosampler wash delay
0.1, 0.5, 1, 2, 5, 10, 20 μg/L
Linear through zero
DRC Vented (standard mode)
DCR Pressurized (enhanced mode)
Cell q parameter
Cell a parameter
NH3 at 0.5 mL/min
Since the thyroid gland includes a liquid phase (colloid) in addition to the solid phase (cellular), with the possibility of variations of the ratio of the two phases after treatment, measured element values were normalized by both tissue weight and DNA content.
Statistical analysis was carried out with the Analyse-it software, version 2.22, Microsoft Excel (Analyse-it Software, Ltd.) by 2-way unpaired t-test. A p-value <0.05 was considered statistically significant.
Boron, Cadmium, and Molybdenum do not cause overt toxicity
Boron, Cadmium, and Molybdenum accelerate and worsen thyroid abnormalities induced by goitrogenic diet
To investigate the effect of metal supplementation on the thyroid, animals were sacrificed at two experimental time points, 5 and 10 months after the beginning of treatment, and their thyroid gland was analysed. Thyroids of the A and B groups were also compared with those of healthy untreated rats.
As a consequence of the hypothyroidism induced by the goitrogenic diet, the thyroid of both A and B groups was markedly enlarged compared with that of untreated rats in agreement with previous report [25, 27]. No difference was observed in the thyroid volume between groups A and B.
Cumulative morphological features of the thyroid in group A and B
- Disomogeneity (mild)
- Nuclear clearing
- Papillary structures
Vascular congestion (mild)
- Disomogeneity (mild)
- Nuclear clearing (mild)
- Papillary structures (mild)
Vascular congestion (mild)
After 5 months, in 2 out of 5 rats of group B, additional disomogeneity of the follicles characterised by nodular hyperplasia with either pseudonodular or nodular pattern was observed. Cell morphology showed abnormal nuclear morphology with marks of clearing (Fig. 3c, Table 3). This last feature characterises both benign and malignant lesions and is a diagnostic marker of cell transformation when associated with diffuse well-defined papillary structures .
After 10 months of goitrogenic diet, the architectural pattern of the thyroid was further compromised with complete disorganization of the follicular structure, discrete amount of vascularization and increased number of hyperplastic, granular and oxyphilic cells in both groups (Fig. 3d-f, Table 3). In fact, the appearance of these cells is related to the hypothyroidism caused by MMI and low-iodine diet and characterises both benign and malignant thyroid lesions [31, 32]. In rats from group B, thyroid cells presented additional neoplastic features defined by the presence of granular and nuclear pseudo-inclusions.
The presence of papillary structures became evident in the thyroid of hypothyroid rats of both A and B groups, in agreement with previous reports (Fig. 3g-h, Table 3). However, the presence of these structures was markedly increased in the thyroid of group B (Table 3). In addition, in these animals the papillary structures were associated with the appearance of abnormal nuclear morphology and nuclear pseudo-inclusion, markers of cell transformation (Fig. 3f). No overt signs of inflammation were observed in the thyroid of the animals of both groups (Fig. 3).
Concentrations of chemical elements in rat thyroid samples
We, therefore, analysed whether the studied elements accumulate in the thyroid of metal-treated rats. However, the levels of B and Mo did not differ between Group A and B (Table 4), thus excluding a mechanism of competition/replacement. Cd levels were undetectable in both groups. Overall, these data indicate that the histopathological features observed in the thyroid of element-treated rats are not due to an increased concentration of the three elements and suggest that metal supplementation may interfere with iodine uptake.
Our study indicates that in Wistar female rats fed with a goitrogenic diet, additional administration of low levels of Boron, Cadmium, and Molybdenum causes an increase of thyroid abnormalities.
The goitrogenic diet, per se, has been widely reported to induce thyroid tumorigenesis . Rats exposed to this diet, develop various features of cell transformation: nuclear aberrations, change of cell morphology and, most important, papillary structures. Whereas most of these features are present also in benign lesions, the presence of papillary structures in association with nuclear aberrations may be bona fide recognized as a marker of thyroid carcinoma. In control rats (group A), these features of malignant transformation were evident in only one animal after 10 months of goitrogenic diet. Conversely, in element-treated rats (group B), these alterations were more frequent, with the presence of papillary structures occurring in all animals of the group at the same time point. These data suggest that even a slight increase of Boron, Cadmium, and Molybdenum in the diet may accelerate and/or promote the process of cell transformation, thus acting as a tumor-promoting agent rather than a carcinogen. Indeed, in rats treated with low iodine diet, with or without a goitrogenic drug, thyroid tumors occur with high frequency after 18 months [26, 28] while when the low-dose elements were added to the diet, clear marks of follicular cell transformation were observed at 10 months.
The genotoxic effect of some metals is well recognized. Specifically, the overall carcinogenicity of Cd is well established . Conversely, no similar evidence has been reported for B and Mo that may have rather a protective effect on genotoxicity through a variety of different mechanisms [34–38]. The few published data concern their activity on thyroid function and these functional data are often inconsistent and not comparable because of the different experimental models and different study design. To our knowledge, the effect of low concentration of these metals on thyroid carcinogenesis has never been reported.
In fact, a major novelty of our study is that the studied elements were supplemented in the μg or μM range and at concentrations within the non-toxic range while previous studies have used metals in the mg or mM range. Moreover, in most of the previous studies, the exposure to metals was usually short-lasting (days or weeks) whereas we examined low-dose chronic effects as occur in the residents of the volcanic area where thyroid cancer incidence is increased.
The molecular mechanism of the thyroid transforming activity of B, Cd, and Mo at low, non-toxic dose remains unclear. Our data show that these elements impair the iodine uptake from thyroid. However, the mechanism by which this occurs remains to be ascertained. One possibility is that the mixture of elements may enhance the specific detrimental effect of each chemical because of the synergistic consequences of disrupting multiple cellular mechanisms. Additionally, the reduced iodine content in the thyroid of element-treated rats could be due to decreased uptake and hormonogenesis due to the increased follicular cell transformation.
Our current understanding of heavy metals’ and metalloids’ effect on the thyroid is very limited because the toxicological profile of water-soluble chemicals and their tissue-specific tumorigenic potential is still insufficient. A quantitative, poorly-investigated mechanism, for instance, is the hormesis effect, a biphasic dose-response relationship already documented in vitro for different metals, including Cd [39, 40]. Hormesis is characterised by stimulation of biological effects at lower concentrations and inhibition at higher concentrations  and has important toxicological implications for the potential consequences of chronic exposure to very low levels of many toxicants . The U-shaped immune function response characteristic of low and high doses of B supplementation in rats  could involve this mechanism. In this context, the reduced iodine content in the thyroid of elements-treated rats may play an additional role.
In conclusion, chronic exposure of hypothyroid rats to B, Cd, and Mo at the levels found in drinking water of Mt. Etna volcanic area, causes an accelerated appearance of features of malignant transformation in thyroid cells. This study has to be considered an exploratory analysis suggesting a possible cause-effect relationship between thyroid cancer and the combination of the tested elements. Further studies will be necessary to ascertain the evolution of clinically evident thyroid tumors and the mechanism/s involved. Given the high prevalence of population exposure to metals in the industrialized world, this work warrants in-depth molecular studies on the activity of different metals in thyroid carcinogenesis.
This work was supported by PRIN 2008SYHYKS to AP and RV, by AIRC IG 12,767 to FM.
Availability of data and materials
All data generated or analysed during this study are included in this published article. Additional material presented in the current study is available from the corresponding authors on reasonable request.
EL and LF contributed equally to this work by performing the histochemistry experiments and with animals respectively. EL contributed to the writing of the manuscript. AR performed the analysis of metals in samples. FM and EDR performed histochemistry analysis in collaboration with EL. MEC collaborated in the maintenance of the animals. PM and MR worked on the literature search and, together with AP contributed to the critical evaluation of the work. RV, AP, and FM designed and oversaw the study. RV and FM conducted scientific direction and wrote the manuscript. All authors read/reviewed and approved the final manuscript.
The authors declare that they have no competing interests.
Consent for publication
All animal experiments were approved by the ethical committee of the Catholic University of Rome, Italy (UCSC Approval N. Q42).
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Pellegriti G, Frasca F, Regalbuto C, Squatrito S, Vigneri R. Worldwide increasing incidence of thyroid cancer: update on epidemiology and risk factors. J Cancer Epidemiol. 2013;2013:965212.View ArticlePubMedPubMed CentralGoogle Scholar
- Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973–2002. Jama. 2006;295:2164–7.View ArticlePubMedGoogle Scholar
- Simard EP, Ward EM, Siegel R, Jemal A. Cancers with increasing incidence trends in the United States: 1999 through 2008. CA Cancer J Clin. 2012;62:118–28.View ArticlePubMedGoogle Scholar
- Ito Y, Nikiforov YE, Schlumberger M, Vigneri R. Increasing incidence of thyroid cancer: controversies explored. Nat Rev Endocrinol. 2013;9:178–84.View ArticlePubMedGoogle Scholar
- Vigneri R, Malandrino P, Vigneri P. The changing epidemiology of thyroid cancer: why is incidence increasing? Curr Opin Oncol. 2015;27:1–7.View ArticlePubMedGoogle Scholar
- Zimmermann MB, Boelaert K. Iodine deficiency and thyroid disorders. Lancet Diabetes Endocrinol. 2015;3:286–95.Google Scholar
- Saenko V, Ivanov V, Tsyb A, Bogdanova T, Tronko M, Demidchik Y, Yamashita S. The Chernobyl accident and its consequences. Clin Oncol (R Coll Radiol). 2011;23:234–43.View ArticleGoogle Scholar
- Zimmermann MB, Galetti V. Iodine intake as a risk factor for thyroid cancer: a comprehensive review of animal and human studies. Thyroid Res. 2015;8:8.View ArticlePubMedPubMed CentralGoogle Scholar
- Centanni M, Maiani G, Vermiglio F, Canettieri G, Sanna AL, Moretti F, Trimarchi F, Andreoli M. Combined impairment of nutritional parameters and thyroid homeostasis in mildly iodine-deficient children. Thyroid. 1998;8:155–9.View ArticlePubMedGoogle Scholar
- Marcello MA, Malandrino P, Almeida JF, Martins MB, Cunha LL, Bufalo NE, Pellegriti G, Ward LS. The influence of the environment on the development of thyroid tumors: a new appraisal. Endocr Relat Cancer. 2014;21:T235–54.View ArticlePubMedGoogle Scholar
- Pellegriti G, De Vathaire F, Scollo C, Attard M, Giordano C, Arena S, Dardanoni G, Frasca F, Malandrino P, Vermiglio F, et al. Papillary thyroid cancer incidence in the volcanic area of Sicily. J Natl Cancer Inst. 2009;101:1575–83.View ArticlePubMedGoogle Scholar
- Malandrino P, Scollo C, Marturano I, Russo M, Tavarelli M, Attard M, Richiusa P, Violi MA, Dardanoni G, Vigneri R, Pellegriti G. Descriptive epidemiology of human thyroid cancer: experience from a regional registry and the “volcanic factor”. Front Endocrinol (Lausanne). 2013;4:65.Google Scholar
- Kolonel LN, Hankin JH, Wilkens LR, Fukunaga FH, Hinds MW. An epidemiologic study of thyroid cancer in Hawaii. Cancer Causes Control. 1990;1:223–34.View ArticlePubMedGoogle Scholar
- Arnbjornsson E, Arnbjornsson A, Olafsson A. Thyroid cancer incidence in relation to volcanic activity. Arch Environ Health. 1986;41:36–40.View ArticlePubMedGoogle Scholar
- Malandrino P, Russo M, Ronchi A, Minoia C, Cataldo D, Regalbuto C, Giordano C, Attard M, Squatrito S, Trimarchi F, Vigneri R. Increased thyroid cancer incidence in a basaltic volcanic area is associated with non-anthropogenic pollution and biocontamination. Endocrine. 2016;53:471–9.View ArticlePubMedGoogle Scholar
- Armstrong TA, Spears JW, Lloyd KE. Inflammatory response, growth, and thyroid hormone concentrations are affected by long-term boron supplementation in gilts. J Anim Sci. 2001;79:1549–56.View ArticlePubMedGoogle Scholar
- Kudabayeva KI, Koshmaganbetova GK, Mickuviene N, Skalnaya MG, Tinkov AA, Skalny AV. Hair Trace Elements are Associated with Increased Thyroid Volume in Schoolchildren with Goiter. Biol Trace Elem Res. 2016;174:261–6.View ArticlePubMedGoogle Scholar
- Faure R, Dussault JH. Interaction of sodium molybdate with the thyroid hormone receptor. Biochem Cell Biol. 1990;68:630–4.View ArticlePubMedGoogle Scholar
- Celik T, Savas N, Kurtoglu S, Sangun O, Aydin Z, Mustafa D, Ozturk OH, Misirlioglu S, Oktem M. Iodine, copper, zinc, selenium and molybdenum levels in children aged between 6 and 12 years in the rural area with iodine deficiency and in the city center without iodine deficiency in Hatay. Turk Pediatri Ars. 2014;49:111–6.View ArticlePubMedPubMed CentralGoogle Scholar
- Jancic SA, Stosic BZ. Cadmium effects on the thyroid gland. Vitam Horm. 2014;94:391–425.View ArticlePubMedGoogle Scholar
- Tiran B, Karpf E, Tiran A. Age dependency of selenium and cadmium content in human liver, kidney, and thyroid. Arch Environ Health. 1995;50:242–6.View ArticlePubMedGoogle Scholar
- Yorita Christensen KL. Metals in blood and urine, and thyroid function among adults in the United States 2007-2008. Int J Hyg Environ Health. 2013;216:624–32.View ArticlePubMedGoogle Scholar
- Chung HK, Nam JS, Ahn CW, Lee YS, Kim KR. Some Elements in Thyroid Tissue are Associated with More Advanced Stage of Thyroid Cancer in Korean Women. Biol Trace Elem Res. 2016;171:54–62.View ArticlePubMedGoogle Scholar
- Axelrad AA, Leblond CP. Induction of thyroid tumors in rats by a low iodine diet. Cancer. 1955;8:339–67.View ArticlePubMedGoogle Scholar
- Kanno J, Matsuoka C, Furuta K, Onodera H, Miyajima H, Maekawa A, Hayashi Y. Tumor promoting effect of goitrogens on the rat thyroid. Toxicol Pathol. 1990;18:239–46.View ArticlePubMedGoogle Scholar
- Ohshima M, Ward JM. Dietary iodine deficiency as a tumor promoter and carcinogen in male F344/NCr rats. Cancer Res. 1986;46:877–83.PubMedGoogle Scholar
- Sarne D. Effects of the Environment, Chemicals and Drugs on Thyroid Function. In: De Groot LJ, Beck-Peccoz P, Chrousos G, Dungan K, Grossman A, Hershman JM, Koch C, McLachlan R, New M, Rebar R, et al., editors. Endotext. South Dartmouth (MA): MDText.com, Inc; 2000.Google Scholar
- Ward JM, Ohshima M. The role of iodine in carcinogenesis. Adv Exp Med Biol. 1986;206:529–42.PubMedGoogle Scholar
- Derwahl M, Nicula D. Estrogen and its role in thyroid cancer. Endocr Relat Cancer. 2014;21:T273–83.View ArticlePubMedGoogle Scholar
- LiVolsi VA. Papillary thyroid carcinoma: an update. Mod Pathol. 2011;24 Suppl 2:S1–9.View ArticlePubMedGoogle Scholar
- Asa SL. My approach to oncocytic tumours of the thyroid. J Clin Pathol. 2004;57:225–32.View ArticlePubMedPubMed CentralGoogle Scholar
- Harach HR, Virgili E, Soler G, Zusman SB, Saravia Day E. Cytopathology of follicular tumours of the thyroid with clear cell change. Cytopathology. 1991;2:125–35.View ArticlePubMedGoogle Scholar
- Waisberg M, Joseph P, Hale B, Beyersmann D. Molecular and cellular mechanisms of cadmium carcinogenesis. Toxicology. 2003;192:95–117.View ArticlePubMedGoogle Scholar
- Ince S, Kucukkurt I, Cigerci IH, Fatih Fidan A, Eryavuz A. The effects of dietary boric acid and borax supplementation on lipid peroxidation, antioxidant activity, and DNA damage in rats. J Trace Elem Med Biol. 2010;24:161–4.View ArticlePubMedGoogle Scholar
- Zafar H, Ali S. Boron inhibits the proliferating cell nuclear antigen index, molybdenum containing proteins and ameliorates oxidative stress in hepatocellular carcinoma. Arch Biochem Biophys. 2013;529:66–74.View ArticlePubMedGoogle Scholar
- Teknos TN, Islam M, Arenberg DA, Pan Q, Carskadon SL, Abarbanell AM, Marcus B, Paul S, Vandenberg CD, Carron M, et al. The effect of tetrathiomolybdate on cytokine expression, angiogenesis, and tumor growth in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg. 2005;131:204–11.View ArticlePubMedGoogle Scholar
- Panneerselvam SR, Govindasamy S. Effect of sodium molybdate on the status of lipids, lipid peroxidation and antioxidant systems in alloxan-induced diabetic rats. Clin Chim Acta. 2004;345:93–8.View ArticlePubMedGoogle Scholar
- Jakobsen SS, Danscher G, Stoltenberg M, Larsen A, Bruun JM, Mygind T, Kemp K, Soballe K. Cobalt-chromium-molybdenum alloy causes metal accumulation and metallothionein up-regulation in rat liver and kidney. Basic Clin Pharmacol Toxicol. 2007;101:441–6.View ArticlePubMedGoogle Scholar
- Calabrese EJ. Hormesis: a revolution in toxicology, risk assessment and medicine. EMBO Rep. 2004;5 Spec No:S37–40.View ArticlePubMedGoogle Scholar
- Jiang G, Duan W, Xu L, Song S, Zhu C, Wu L. Biphasic effect of cadmium on cell proliferation in human embryo lung fibroblast cells and its molecular mechanism. Toxicol In Vitro. 2009;23:973–8.View ArticlePubMedGoogle Scholar
- Cook R, Calabrese EJ. The importance of hormesis to public health. Environ Health Perspect. 2006;114:1631–5.PubMedPubMed CentralGoogle Scholar
- Jin E, Li S, Ren M, Hu Q, Gu Y, Li K. Boron Affects Immune Function ThroughModulation of Splenic T Lymphocyte Subsets, Cytokine Secretion, and LymphocyteProliferation and Apoptosis in Rats. Biol Trace Elem Res. 2017. doi:10.1007/s12011-017-0932-3. [Epub ahead of print].